| | |||||
| in | |||||
| NEWS | |||||
| Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination Data on immunity to other coronaviruses suggest that immunity to SARS-CoV-2 might be short lived, perhaps 12–18 months in duration.
| |||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment